Ionis Pharmaceuticals | IONS - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
Astellas Pharma JPY 43.52B 56.86B 2026-03
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Celltrion KRW 8.88B 322.47B 2025-12
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exelixis USD 210.47M 34.06M 2026-03
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 3.16B 747M 2026-03
Omeros USD -32.23M 23.81M 2024-09
OPKO Health USD -31.26M 52.89M 2025-12
Organigram Holdings CAD 19.97M 57.93M 2025-12
Ovoca Bio EUR -765K 4.89M 2025-06
Pfizer USD 2.69B 4.34B 2026-03
Pharma Mar EUR 1.53M 58.13M 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Qiagen NV USD 107.83M 22.21M 2025-12
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tilray USD -44.93M 44.61M 2025-09
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03